Altman’s Merge Labs Takes Non-Invasive Approach to Brain-Computer Interface
Sam Altman’s Neuralink competitor Merge Labs is taking shape with a key hire that suggests a fundamentally different approach to brain-computer interfaces. The company appears to be pursuing non-invasive methods using gene therapy and ultrasound technology.
